The Impact of Secondary Catheter-Related Bloodstream Infection on the Course of COVID-19 Infection

IF 0.4 Q4 INFECTIOUS DISEASES Infectious Diseases in Clinical Practice Pub Date : 2024-01-15 DOI:10.1097/ipc.0000000000001343
Y. Nadir, P. Kiran, Damla Erturk, Uğur Uzun, T. Yavuz, G. Ersan, Hale Turan Ozden, S. S. Senger
{"title":"The Impact of Secondary Catheter-Related Bloodstream Infection on the Course of COVID-19 Infection","authors":"Y. Nadir, P. Kiran, Damla Erturk, Uğur Uzun, T. Yavuz, G. Ersan, Hale Turan Ozden, S. S. Senger","doi":"10.1097/ipc.0000000000001343","DOIUrl":null,"url":null,"abstract":"\n \n \n Secondary bacterial infections can worsen the prognosis for COVID-19, especially in patients with severe infections. Thus, we aim to investigate the effect of secondary catheter-related bloodstream infections on the course of COVID-19 infection.\n \n \n \n This is a retrospective, nested case-control study and included 236 confirmed COVID-19 infection hospitalized patients, divided into 2 groups (COVID-19, n = 64; non–COVID-19, n = 172) according to SARS-CoV-2 RT-PCR results.\n \n \n \n The age, sex, and prevalence of chronic diseases were similar in both groups. Klebsiella pneumoniae (31.2%) and Acinetobacter baumannii (21.9%) were the predominant microorganisms in the COVID-19 group. Only A. baumannii was statistically higher in the COVID-19 group (P = 0.046). There were no significant differences in terms of resistance profiles. The 30-day mortality was significantly higher in the COVID-19 group (56.3%) than in the non–COVID-19 group (38.4%) (P = 0.014). There was no significant difference in the length of stay between the 2 groups. The multiple logistic regression analysis of risk factors for 30-day mortality revealed that COVID-19 positivity (odds ratio [OR], 2.167; 95% confidence interval [CI], 1.056–4.446; P = 0.035), infection with extensively drug-resistant bacteria (OR, 2.949; 95% CI, 1.311–6.636; P = 0.009), and infection with pandrug-resistant bacteria (OR, 3.601; 95% CI, 1.213–10.689; P = 0.021) were independent risk factors for 30-day mortality.\n \n \n \n As a conclusion, this study demonstrated that COVID-19 positivity is an independent risk factor for 30-day mortality of secondary catheter-related bloodstream infections. Gram-negative bacteria were the predominant microorganisms, with A. baumannii being statistically higher in the COVID-19 group compared with the non–COVID-19 group. However, there were no statistically significant differences in terms of the resistance profile of microorganisms.\n","PeriodicalId":13952,"journal":{"name":"Infectious Diseases in Clinical Practice","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2024-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious Diseases in Clinical Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ipc.0000000000001343","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Secondary bacterial infections can worsen the prognosis for COVID-19, especially in patients with severe infections. Thus, we aim to investigate the effect of secondary catheter-related bloodstream infections on the course of COVID-19 infection. This is a retrospective, nested case-control study and included 236 confirmed COVID-19 infection hospitalized patients, divided into 2 groups (COVID-19, n = 64; non–COVID-19, n = 172) according to SARS-CoV-2 RT-PCR results. The age, sex, and prevalence of chronic diseases were similar in both groups. Klebsiella pneumoniae (31.2%) and Acinetobacter baumannii (21.9%) were the predominant microorganisms in the COVID-19 group. Only A. baumannii was statistically higher in the COVID-19 group (P = 0.046). There were no significant differences in terms of resistance profiles. The 30-day mortality was significantly higher in the COVID-19 group (56.3%) than in the non–COVID-19 group (38.4%) (P = 0.014). There was no significant difference in the length of stay between the 2 groups. The multiple logistic regression analysis of risk factors for 30-day mortality revealed that COVID-19 positivity (odds ratio [OR], 2.167; 95% confidence interval [CI], 1.056–4.446; P = 0.035), infection with extensively drug-resistant bacteria (OR, 2.949; 95% CI, 1.311–6.636; P = 0.009), and infection with pandrug-resistant bacteria (OR, 3.601; 95% CI, 1.213–10.689; P = 0.021) were independent risk factors for 30-day mortality. As a conclusion, this study demonstrated that COVID-19 positivity is an independent risk factor for 30-day mortality of secondary catheter-related bloodstream infections. Gram-negative bacteria were the predominant microorganisms, with A. baumannii being statistically higher in the COVID-19 group compared with the non–COVID-19 group. However, there were no statistically significant differences in terms of the resistance profile of microorganisms.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
继发性导管相关血流感染对 COVID-19 感染病程的影响
继发性细菌感染会恶化 COVID-19 的预后,尤其是严重感染的患者。因此,我们旨在研究继发性导管相关血流感染对 COVID-19 感染病程的影响。 这是一项回顾性、巢式病例对照研究,共纳入 236 名确诊 COVID-19 感染的住院患者,根据 SARS-CoV-2 RT-PCR 结果分为两组(COVID-19,64 人;非 COVID-19,172 人)。 两组患者的年龄、性别和慢性病患病率相似。肺炎克雷伯菌(31.2%)和鲍曼不动杆菌(21.9%)是 COVID-19 组的主要微生物。据统计,只有鲍曼不动杆菌在 COVID-19 组中含量更高(P = 0.046)。耐药性方面没有明显差异。COVID-19 组的 30 天死亡率(56.3%)明显高于非 COVID-19 组(38.4%)(P = 0.014)。两组患者的住院时间无明显差异。对 30 天死亡率风险因素的多重逻辑回归分析显示,COVID-19 阳性(几率比 [OR],2.167;95% 置信区间 [CI],1.056-4.446;P = 0.035)、感染广泛耐药菌(OR,2.949;95% CI,1.311-6.636;P = 0.009)和感染泛耐药菌(OR,3.601;95% CI,1.213-10.689;P = 0.021)是 30 天死亡率的独立风险因素。 综上所述,本研究表明 COVID-19 阳性是继发性导管相关血流感染 30 天死亡率的独立风险因素。革兰氏阴性菌是主要的微生物,COVID-19 阳性组中的鲍曼不动杆菌在统计学上高于非 COVID-19 阳性组。不过,在微生物的耐药性方面,两者之间并无统计学上的显著差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
78
期刊介绍: Medical professionals seeking an infectious diseases journal with true clinical value need look no further than Infectious Diseases in Clinical Practice. Here, clinicians can get full coverage consolidated into one resource, with pertinent new developments presented in a way that makes them easy to apply to patient care. From HIV care delivery to Hepatitis C virus testing…travel and tropical medicine…and infection surveillance, prevention, and control, Infectious Diseases in Clinical Practice delivers the vital information needed to optimally prevent and treat infectious diseases. Indexed/abstracted in: EMBASE, SCOPUS, Current Contents/Clinical Medicine
期刊最新文献
The Etiologic Organisms, Risk Factors, and Outcomes of Nosocomial Bloodstream Infections in Pediatric Patients Evaluation of Empirical Antibiotic Therapy in Women With Acute Cystitis Visiting Outpatient Clinic in South Korea Mucormycosis in Diabetes Determinants of Mortality in COVID-19–Associated Opportunistic Fungal Infections Ceftaroline Fosamil as a Potential Treatment for Central Nervous System Infections in Children
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1